Skip to main content
SpringerLink
Log in

2020 update of the Austrian Society of Cardiology (ÖKG) and the Austrian Society of Cardiac Surgery (ÖGHTG) on the position statement of the ÖKG and ÖGHTG for transcatheter aortic valve implantation 2011

  • position paper
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

This position statement is an update to the 2011 consensus statement of the Austrian Society of Cardiology (ÖKG) and the Austrian Society of Cardiac Surgery (ÖGTHG) for transfemoral transcatheter aortic valve implantation.

Due to a number of recently published studies, broadening of indications and recommendations of medical societies and our own national developments, the ÖKG and the ÖGHTG wish to combine the 2017 ESC/EACTS guidelines for the management of valvular heart disease with a national position paper and to focus on certain details for the application in Austria. Thus, this position statement serves as a supplement and further interpretation of the international guidelines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

AS:

Aortic stenosis

AVA:

Aortic valve area

BAV:

Balloon valvuloplasty

CMR:

Cardiac magnetic resonance imaging

EACTS:

European Society of Cardiothoracic Surgery

ESC:

European Society of Cardiology

ECMO:

Extracorporeal membrane oxygenation

LV:

Left ventricular

LVOT:

Left ventricular outflow tract

MSCT:

Multi-slice-computed-tomography

ÖGHTG:

Austrian Society of Cardiac Surgery

ÖKG:

Austrian Society of Cardiology

PCI:

Percutaneous coronary intervention

TAVI:

Transcatheter aortic valve implantation

SAVR:

Surgical aortic valve replacement

References

  1. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91.

    Article  PubMed  Google Scholar 

  2. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20.

    Article  CAS  PubMed  Google Scholar 

  3. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–31.

    Article  PubMed  Google Scholar 

  4. Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–25.

    Article  PubMed  Google Scholar 

  5. Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382:799–809.

    Article  PubMed  Google Scholar 

  6. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–705.

    Article  PubMed  Google Scholar 

  7. Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–15.

    Article  PubMed  Google Scholar 

  8. Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review. Eur J Intern Med. 2016;31:3–10.

    Article  PubMed  Google Scholar 

  9. Makkar RR, Jilaihawi H, Mack M, Chakravarty T, Cohen DJ, Cheng W, et al. Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons. J Am Coll Cardiol. 2014;63:901–11.

    Article  PubMed  Google Scholar 

  10. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142–7.

    Article  CAS  PubMed  Google Scholar 

  11. Beach JM, Mihaljevic T, Svensson LG, Rajeswaran J, Marwick T, Griffin B, et al. Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2013;61:837–48.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Czer LS, Gray RJ, Stewart ME, De Robertis M, Chaux A, Matloff JM. Reduction in sudden late death by concomitant revascularization with aortic valve replacement. J Thorac Cardiovasc Surg. 1988;95:390–401.

    Article  CAS  PubMed  Google Scholar 

  13. Goel SS, Agarwal S, Tuzcu EM, Ellis SG, Svensson LG, Zaman T, et al. Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacement. Circulation. 2012;125:1005–13.

    Article  PubMed  Google Scholar 

  14. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.

    Article  CAS  PubMed  Google Scholar 

  15. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.

    Article  CAS  PubMed  Google Scholar 

  16. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705–15.

    Article  CAS  PubMed  Google Scholar 

  17. Nombela-Franco L, Ribeiro HB, Urena M, Allende R, Amat-Santos I, DeLarochelliere R, et al. Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. J Am Coll Cardiol. 2014;63:2643–58.

    Article  PubMed  Google Scholar 

  18. Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, et al. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol. 2013;112:272–9.

    Article  PubMed  Google Scholar 

  19. Chakravarty T, Van Belle E, Jilaihawi H, Noheria A, Testa L, Bedogni F, et al. Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. Am J Cardiol. 2015;115:942–9.

    Article  PubMed  Google Scholar 

  20. Diaz R, Hernandez-Vaquero D, Alvarez-Cabo R, Avanzas P, Silva J, Moris C, et al. Long-term outcomes of mechanical versus biological aortic valve prosthesis: systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2019;158:706–714.e18.

    Article  PubMed  Google Scholar 

  21. Puskas JD, Gerdisch M, Nichols D, Fermin L, Rhenman B, Kapoor D, et al. Anticoagulation and antiplatelet strategies after on‑X mechanical aortic valve replacement. J Am Coll Cardiol. 2018;71:2717–26.

    Article  CAS  PubMed  Google Scholar 

  22. Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, et al. 3‑year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67:2565–74.

    Article  PubMed  Google Scholar 

  23. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5‑year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2477–84.

    Article  PubMed  Google Scholar 

  24. Sondergaard L, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Two-year outcomes in patients with severe aortic valve stenosis randomized to transcatheter versus surgical aortic valve replacement: the all-comers nordic aortic valve intervention randomized clinical trial. Circ Cardiovasc Interv. 2016;9(6):e3665.

    Article  PubMed  Google Scholar 

  25. Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1‑year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184–94.

    Article  PubMed  Google Scholar 

  26. Sondergaard L, Ihlemann N, Capodanno D, Jorgensen TH, Nissen H, Kjeldsen BJ, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 2019;73:546–53.

    Article  PubMed  Google Scholar 

  27. Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5‑year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2485–91.

    Article  PubMed  Google Scholar 

  28. Siemieniuk RA, Agoritsas T, Manja V, Devji T, Chang Y, Bala MM, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis. BMJ. 2016;354:i5130.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Vandvik PO, Otto CM, Siemieniuk RA, Bagur R, Guyatt GH, Lytvyn L, et al. Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline. BMJ. 2016;354:i5085.

    Article  PubMed  Google Scholar 

  30. Carroll JD, Vemulapalli S, Dai D, Matsouaka R, Blackstone E, Edwards F, et al. Procedural experience for transcatheter aortic valve replacement and relation to outcomes: the STS/ACC TVT registry. J Am Coll Cardiol. 2017;70:29–41.

    Article  PubMed  Google Scholar 

  31. Wassef AWA, Rodes-Cabau J, Liu Y, Webb JG, Barbanti M, Munoz-Garcia AJ, et al. The learning curve and annual procedure volume standards for optimum outcomes of transcatheter aortic valve replacement: findings from an international registry. JACC Cardiovasc Interv. 2018;11:1669–79.

    Article  PubMed  Google Scholar 

  32. Vemulapalli S, Carroll JD, Mack MJ, Li Z, Dai D, Kosinski AS, et al. Procedural volume and outcomes for transcatheter aortic-valve replacement. N Engl J Med. 2019; https://doi.org/10.1056/NEJMsa1901109.

    Article  PubMed  Google Scholar 

  33. Bestehorn K, Eggebrecht H, Fleck E, Bestehorn M, Mehta RH, Kuck KH. Volume-outcome relationship with transfemoral transcatheter aortic valve implantation (TAVI): insights from the compulsory German quality assurance registry on aortic valve replacement (AQUA). EuroIntervention. 2017;13:914–20.

    Article  PubMed  Google Scholar 

  34. Inohara T, Hayashida K, Watanabe Y, Yamamoto M, Takagi K, Yashima F, et al. Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries. Catheter Cardiovasc Interv. 2016;87:963–70.

    Article  PubMed  Google Scholar 

  35. Eggebrecht H, Bestehorn M, Haude M, Schmermund A, Bestehorn K, Voigtlander T, et al. Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients. Eur Heart J. 2016;37:2240–8.

    Article  PubMed  Google Scholar 

  36. Eggebrecht H, Schmermund A. The current situation and the future of emergent cardiac surgery in TAVI. Interv Cardiol. 2015;10:55–7.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, et al. Rupture of the device landing zone during transcatheter aortic valve implantation: a life-threatening but treatable complication. Circ Cardiovasc Interv. 2012;5:424–32.

    Article  PubMed  Google Scholar 

  38. Hamm CW, Mollmann H, Holzhey D, Beckmann A, Veit C, Figulla HR, et al. The German aortic valve registry (GARY): in-hospital outcome. Eur Heart J. 2014;35:1588–98.

    Article  PubMed  Google Scholar 

  39. Egger F, Zweiker D, Freynhofer MK, Loffler V, Rohla M, Geppert A, et al. Impact of on-site cardiac surgery on clinical outcomes after transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11:2160–7.

    Article  PubMed  Google Scholar 

  40. Babaliaros V, Devireddy C, Lerakis S, Leonardi R, Iturra SA, Mavromatis K, et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014;7:898–904.

    Article  PubMed  Google Scholar 

  41. Gurevich S, Oestreich B, Kelly RF, Mbai M, Bertog S, Ringsred K, et al. Outcomes of transcatheter aortic valve replacement using a minimalist approach. Cardiovasc Revasc Med. 2018;19:192–5.

    Article  PubMed  Google Scholar 

  42. Spaziano M, Lefevre T, Romano M, Eltchaninoff H, Leprince P, Motreff P, et al. Transcatheter aortic valve replacement in the catheterization laboratory versus hybrid operating room: insights from the FRANCE TAVI registry. JACC Cardiovasc Interv. 2018;11:2195–203.

    Article  PubMed  Google Scholar 

  43. Deharo P, Jaussaud N, Grisoli D, Camus O, Resseguier N, Le Breton H, et al. Impact of direct transcatheter aortic valve replacement without balloon aortic valvuloplasty on procedural and clinical outcomes: insights from the FRANCE TAVI registry. JACC Cardiovasc Interv. 2018;11:1956–65.

    Article  PubMed  Google Scholar 

  44. Toggweiler S, Stortecky S, Holy E, Zuk K, Cuculi F, Nietlispach F, et al. The electrocardiogram after transcatheter aortic valve replacement determines the risk for post-procedural high-degree AV block and the need for telemetry monitoring. JACC Cardiovasc Interv. 2016;9:1269–76.

    Article  PubMed  Google Scholar 

  45. Brouwer J, et al. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med. 2020; https://doi.org/10.1056/NEJMoa2017815.

    Article  PubMed  Google Scholar 

  46. von Scheidt W, et al. Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI) : joint consensus document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e. V. (ALKK) and cooperating cardiac surgery department. Clin Res Cardiol. 2020;109:1–12.

    Article  CAS  Google Scholar 

  47. Otto C, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2020; https://doi.org/10.1016/j.jacc.2020.11.018.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Lamm G. New strategies in the management of valvular heart disease. Wien Klin Wochenschr. 2021. (submitted)

Download references

Author information

Authors and Affiliations

  1. Universitätsklinikum St. Pölten, Klinische Abteilung für Innere Medizin 3, Karl Landsteiner Privatuniversität für Gesundheitswissenschaften, Dunant-Platz 1, 3100, St. Pölten, Austria

    Gudrun Lamm

  2. Universitätsklinik für Innere Medizin 2, Kardiologie und Internistische Intensivmedizin, Paracelsus Medizinische Universität Salzburg, Salzburg, Austria

    Matthias Hammerer & Uta C. Hoppe

  3. Universitätsklinik für Chirurgie, Abteilung für Herzchirurgie, Medizinische Universität Wien, Vienna, Austria

    Martin Andreas & Wilfried Wisser

  4. Innere Medizin I, Kardiologie und Nephrologie, Krankenhaus der Barmherzigen Brüder Eisenstadt, Eisenstadt, Austria

    Rudolf Berger & Philipp Pichler

  5. Innere Medizin II , Kardiologie und Intensivmedizin, Klinikum Wels-Grieskirchen, Wels, Austria

    Ronald K. Binder

  6. Universitätsklinik für Herzchirurgie, Universitätsklinik Innsbruck, Innsbruck, Austria

    Nikolaos Bonaros & Michael Grimm

  7. Abteilung für Kardiologie, KH Nord der Stadt Wien, Vienna, Austria

    Georg Delle-Karth

  8. Innere Medizin I mit Kardiologie, Akademisches Lehrkrankenhaus Feldkirch, Feldkirch, Austria

    Matthias Frick

  9. Med. Campus III., Klinik für Kardiologie und internistische Intensivmedizin, Kepler Universitätsklinikum Linz, Linz, Austria

    Michael Grund

  10. Universitätsklinik für Innere Medizin III/Kardiologie, Universitätsklinik Innsbruck, Innsbruck, Austria

    Bernhard Metzler

  11. Universitätsklinikum Krems, Klinische Abteilung für Innere Medizin I, Karl Landsteiner Privatuniversität für Gesundheitswissenschaften, Krems, Austria

    Thomas Neunteufl

  12. Universitätsklinik für Innere Medizin II, Klinische Abteilung für Kardiologie, Medizinische Universität Wien, Vienna, Austria

    Philipp Pichler

  13. Klinische Abteilung für Kardiologie, Medizinische Universitätsklinik Graz, Graz, Austria

    Albrecht Schmidt

  14. Universitätsklinik für Herz‑, Gefäß- und Thoraxchirurgie, Kepler Universitätsklinikum Linz, Linz, Austria

    Andreas Zierer

  15. Klinik für Herz- Gefäß- und Endovaskuläre Chirurgie, Paracelsus Medizinische Privatuniversität Salzburg, Salzburg, Austria

    Rainald Seitelberger

  16. 3. Medizinische Abteilung mit Kardiologie, Wilhelminenspital der Stadt Wien, Vienna, Austria

    Alexander Geppert

Authors
  1. Gudrun Lamm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthias Hammerer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Uta C. Hoppe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Martin Andreas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rudolf Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ronald K. Binder
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nikolaos Bonaros
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Georg Delle-Karth
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Matthias Frick
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Michael Grund
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Bernhard Metzler
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Thomas Neunteufl
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Philipp Pichler
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Albrecht Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Wilfried Wisser
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Andreas Zierer
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Rainald Seitelberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Michael Grimm
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Alexander Geppert
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

ÖKG and ÖGHTG

Corresponding author

Correspondence to Gudrun Lamm.

Ethics declarations

Conflict of interest

G. Lamm: speaker fees from Boston Scientific, Edwards Lifesciences and Medtronic, educational grants from Abbott, Edwards Lifesciences and Medtronic.

M. Andreas: proctor for Edwards Lifesciences and Abbott; advisor for Medtronic.

R.K. Binder: proctor for Boston Scientific, consultant for Edwards Lifesciences, speaker fees and educational grants from Abbott and Medtronic.

N. Bonaros: speaker fees/consultant for Edwards Lifesciences, Abbott, Medtronic, Livanova. Educational Grants/Research Grants from Edwards Lifesciences, Livanova.

G. Delle-Karth: speaker fees, research and educational grants from Edwards Lifesciences and Medtronic; consultant for Edwards Lifesciences and Medtronic.

A. Geppert: speaker fees from Medtronic, Abbott and Edwards; consultant for Abbott.

M. Hammerer, U.C. Hoppe, R. Berger, M. Frick, M. Grund, B. Metzler, T. Neunteufl, P. Pichler, A. Schmidt, W. Wisser, A. Zierer, R. Seitelberger and M. Grimm declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lamm, G., Hammerer, M., Hoppe, U.C. et al. 2020 update of the Austrian Society of Cardiology (ÖKG) and the Austrian Society of Cardiac Surgery (ÖGHTG) on the position statement of the ÖKG and ÖGHTG for transcatheter aortic valve implantation 2011. Wien Klin Wochenschr 133, 750–761 (2021). https://doi.org/10.1007/s00508-021-01820-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-021-01820-3

Keywords

Search

Navigation